Clinical Therapeutics/New Technology-Insulins

Clinical Therapeutics/New Technology-Insulins

You have access
Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System
Apoorva Ravindranath Waikar, Tanima Arora, Meagan Haynes, William V. Tamborlane, Laura M. Nally

Clinical Diabetes Jun 2021, cd200128; DOI: 10.2337/cd20-0128
You have access
Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
Roque Cardona-Hernandez, Anke Schwandt, Hessa Alkandari, Heiko Bratke, Agata Chobot, Nicole Coles, Sarah Corathers, Damla Goksen, Peter Goss, Zineb Imane, Katrin Nagl, Stephen M.P. O’Riordan, Craig Jefferies

Diabetes Care May 2021, 44 (5) 1176-1184; DOI: 10.2337/dc20-1674
You have access
Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin
Jing Fan Yang, Xun Gong, Naveed A. Bakh, Kelley Carr, Nelson F.B. Phillips, Faramarz Ismail-Beigi, Michael A. Weiss, Michael S. Strano

Diabetes Aug 2020, 69 (8) 1815-1826; DOI: 10.2337/db19-0879
Open Access
Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study
Lawrence Blonde, Julio Rosenstock, Juan Frias, Andreas L. Birkenfeld, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Stefano Del Prato, Vanita R. Aroda

Diabetes Care Mar 2021, 44 (3) 774-780; DOI: 10.2337/dc20-2023
You have access
Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL⁻¹ and Insulin Degludec 100 units · mL⁻¹ in Type 1 Diabetes
Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Chiara Pascucci, Angela Gambelunghe, Geremia B. Bolli, Carmine G. Fanelli, Francesca Porcellati

Diabetes Care Jan 2021, 44 (1) 125-132; DOI: 10.2337/dc20-1033
You have access
Prevalence of and Characteristics Associated With Overbasalization Among Patients With Type 2 Diabetes Using Basal Insulin: A Cross-Sectional Study
Kevin Cowart, Wendy H. Updike, Rashmi Pathak

Clinical Diabetes Apr 2021, 39 (2) 173-175; DOI: 10.2337/cd20-0080
You have access
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
Ildiko Lingvay, John B. Buse, Edward Franek, Melissa V. Hansen, Mette M. Koefoed, Chantal Mathieu, Jeremy Pettus, Karolina Stachlewska, Julio Rosenstock

Diabetes Care Apr 2021, dc202878; DOI: 10.2337/dc20-2878
You have access
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen, Melanie J. Davies, Amoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A. Senior, Robert J. Silver, Roberto Trevisan, Julio Rosenstock

Diabetes Care Apr 2021, dc202877; DOI: 10.2337/dc20-2877
Open Access
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes
Eva Svehlikova, Ines Mursic, Thomas Augustin, Christoph Magnes, David Gerring, Jan Jezek, Daniela Schwarzenbacher, Maria Ratzer, Michael Wolf, Sarah Howell, Leon Zakrzewski, Martina Urschitz, Bernd Tschapeller, Christina Gatschelhofer, Franz Feichtner, Fiona Lawrence, Thomas R. Pieber

Diabetes Care Feb 2021, 44 (2) 448-455; DOI: 10.2337/dc20-1017
You have access
Effect of Afrezza on Glucose Dynamics During HCL Treatment
Alfonso Galderisi, Nathan Cohen, Peter Calhoun, Kristen Kraemer, Marc Breton, Stuart Weinzimer, Eda Cengiz

Diabetes Care Sep 2020, 43 (9) 2146-2152; DOI: 10.2337/dc20-0091

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Insulins

Pages

Navigate

More Information

Other ADA Resources